Moving the back of the eye to the forefrontof research and development.
Learn more about our goals »
Providing the diabetic patient with a low-drug exposure, sustained-release treatment for Diabetic Macular Edema.
Learn more about how ILUVIEN works »
Diabetes is the leading cause of new cases of blindness in adults.
Learn how Alimera Sciences is creating reliable, effective treatments for diabetic retinopathy »
View All Recent News »
May 11, 2012 -- Alimera Sciences, Inc., (Alimera), a biopharmaceutical company that specializes in the research,...
Read More »
May 07, 2012 -- Alimera Sciences, Inc., (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced the Medicines and Healthcare products Regulatory...
April 26, 2012 -- Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its first quarter fiscal...